pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Rare Disease · news · pharmadog
← back to Rare Disease
News mentioning Rare Disease
497
stories
9h
Sanofi gains FDA clearance for Gaucher disease pill
biopharma dive
11h
nChroma halves workforce, BioXcel lets execs go
biospace
11h
Regeneron racks up another first as FDA greenlights generalized myasthenia gravis RNA drug
biospace
12h
Sanofi secures first FDA approval to treat neurological symptoms in rare metabolic disease
biospace
21h
Ramping up: 3 biotechs growing their workforce after series C raises
biospace
1d
White House pulls nomination for FDA nominee Overton
biopharma dive
1d
CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’s
biospace
1d
Summit’s rejection, Isomorphic’s record $5B raise, obesity and Alzheimer’s in the spotlight
biospace
1d
5 acquisitions that forced Big Pharmas to co-parent
biospace
2d
White House yanks Overton nomination hours before committee vote
biospace
2d
Beren wins FDA approval for long-studied rare disease drug
endpoints
2d
FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live Longer
fda press
2d
STAT+: With $173 million, new startup takes aim at sickle cell
stat
2d
STAT+: After death in gene therapy trial for a brain disease, progress is reported
stat
3d
Serious adverse events mar robust efficacy data for Helus’ psychedelic in major depression
biospace
3d
ObesityWeek 2026: Wave outlines case for body composition–based trial design
biospace
3d
STAT+: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issues
stat
3d
BioSpace 40 Under 40 winners Paull, Zhang let patients with rare disease lead the way at BridgeBio
biospace
6d
Argenx is spending billions to push beyond Vyvgart
endpoints
6d
HHS pumps up to $25M into ibogaine, other psychotropic drugs on Veteran’s Day
biospace
6d
Novo submits sickle cell drug; Flagship, Gates Foundation deepen ties
biopharma dive
6d
Biopharma pushes beyond GLP-1s, weight loss at ObesityWeek 2026
biospace
7d
Sofinnova books biggest-ever $815M fund with an eye toward up-and-coming ‘global leaders’
fiercebiotech
7d
Deep dive: Cardiovascular calamities and catalysts
biospace
7d
FDA’s commissioner voucher program reportedly shuttered ahead of Senate vote on Overton
biospace
7d
10 companies hiring in New Jersey
biospace
8d
Capricor parts ways with 10% of staff as FDA decision on DMD cell therapy nears
biospace
8d
Novartis’ Zolgensma woes, BIO’s China plan, GLP-1s’ new safety warning, FDA’s stacked November
biospace
8d
STAT+: MDCalc launches a ‘rumble strip’ for doctors using generative AI tools
stat
9d
FDA's rare disease framework faces its first real test in Capricor’s DMD drug
biospace
← prev
page 1 of 17
next →